These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37377615)

  • 1. Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study.
    Hu Q; Wang Y; Yao S; Mao Y; Liu L; Li Z; Chen Y; Zhang S; Li Q; Zhao Y; Fan X; Cui Y; Zhao K; Liu Z
    Cancer Res Commun; 2023 Jun; 3(6):1057-1066. PubMed ID: 37377615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer.
    Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Kajiwara Y; Okamoto K; Mochizuki S; Tsujimoto H; Shinto E
    Am J Surg Pathol; 2019 Aug; 43(8):1015-1022. PubMed ID: 31094924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
    Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
    Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
    Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
    Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.
    Ueno H; Shinto E; Shimazaki H; Kajiwara Y; Sueyama T; Yamamoto J; Hase K
    Ann Surg Oncol; 2015 May; 22(5):1504-12. PubMed ID: 25395146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.
    Akimoto T; Takasawa A; Takasawa K; Aoyama T; Matsuura M; Tamate M; Iwasaki M; Habata S; Murakami T; Osanai M; Saito T
    Med Mol Morphol; 2022 Dec; 55(4):275-282. PubMed ID: 35876908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.
    Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Aosasa S; Ueno H
    Virchows Arch; 2019 Sep; 475(3):341-348. PubMed ID: 31076902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions.
    Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Kishi Y; Ueno H
    Virchows Arch; 2020 Jul; 477(1):47-55. PubMed ID: 31932918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
    Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
    J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma.
    Sakai A; Nakashima Y; Miyashita Y; Ao T; Kimura Y; Shinto E; Oki E; Shimokawa M; Ueno H; Oda Y; Mori M
    Histopathology; 2021 Aug; 79(2):219-226. PubMed ID: 33595141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis.
    Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
    Am J Surg Pathol; 2014 Oct; 38(10):1380-6. PubMed ID: 24832160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
    González IA; Bauer PS; Liu J; Chatterjee D
    Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Murotani K; Matsui S; Teramukai S; Sugai T; Ajioka Y; Maruo H; Kotaka M; Tsujie M; Munemoto Y; Yamaguchi T; Kuroda H; Fukunaga M; Tomita N; Sugihara K
    Br J Cancer; 2021 Mar; 124(6):1088-1097. PubMed ID: 33414540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis.
    Qin X; Zhao M; Deng W; Huang Y; Cheng Z; Chung JPW; Chen X; Yang K; Chan DYL; Wang H
    Front Oncol; 2022; 12():826830. PubMed ID: 35359399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
    Grosser B; Emmerson J; Reitsam NG; Cunningham D; Nankivell M; Langley RE; Allum WH; Trepel M; Märkl B; Grabsch HI
    Br J Cancer; 2024 Feb; 130(3):457-466. PubMed ID: 38123705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA).
    Reitsam NG; Märkl B; Dintner S; Sipos E; Grochowski P; Grosser B; Sommer F; Eser S; Nerlinger P; Jordan F; Rank A; Löhr P; Waidhauser J
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
    Ao T; Mochizuki S; Kajiwara Y; Yonemura K; Shiraishi T; Nagata K; Shinto E; Okamoto K; Nearchou IP; Shimazaki H; Kishi Y; Okada Y; Ueno H
    Int J Cancer; 2022 May; 150(10):1706-1721. PubMed ID: 35080810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.